Cronos Group Inc (CRON) Stock Price Today
Key Stats
- $1.19BMarket Cap
- -Volume
- HealthSector
- $3.5552W High
- $2.3052W Low
- -Typical Hold Time
- $389.43MEnterprise Value
- -Div Yield
- -Trading Activity
Track Cronos Group Inc (CRON) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Cronos Group Inc has traded between a low of $2.3 and a high of $3.55, highlighting its annual price range. Buy and sell Cronos Group Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Cronos Group Inc
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Most Recent News
Terrestrial Energy rated 'Buy' with 80% upside due to innovative nuclear tech and strong project fundamentals.
Terrestrial Energy is rated as a 'Buy' with a fair value target of $9 per share, suggesting an 80% upside from current levels. The company's IMSR technology uses a replaceable Core-unit and low-enriched uranium fuel, enabling recurring revenues and r...
Shell expands with $16.5B ARC Resources buy and full Tri Star Energy takeover
Shell plc completed a $16.5 billion acquisition of ARC Resources Ltd., boosting its production by 370,000 barrels of oil equivalent per day and targeting 4% annual growth through 2030. The company also agreed to acquire the remaining 67% of Tri Star ...
Teladoc Health cuts 2026 revenue forecast amid insider stock sale and BetterHelp struggles
Teladoc Health's BetterHelp segment saw an 11.6% revenue drop and a near-zero profit margin in Q2 2026, partly due to a shift from cash to insurance payments. The company lowered its full-year 2026 revenue guidance to $2.36-$2.45 billion from $2.48-$...
People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.